Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Technology Industry News Can Architect Capital fix OnlyFans’ payment problems and lead it to a 2028 IPO? OnlyFans may sell 60% stake to Architect Capital at $5.5B valuation. Find out how this could reshape its future, payments, and IPO path by 2028. byPallavi MadhirajuJanuary 31, 2026